Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

Clinical trial NCT01689831 · UNKNOWN

Trial details

NCT number: NCT01689831
Sponsor: JHP Pharmaceuticals LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis Infection

Start date: 2012-05-01
Primary completion: 2012-10-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.